We pointed to the risk of higher launch prices and distorted pricing practices based on projections validated by the nonpartisan Congressional Budget Office.
Ron Wyden: “We pointed to the risk of higher launch prices and distorted pricing practices based on projections validated by the…”
On the recordMarch 21, 2023
Source
congress.govEditor's note · Context
Wyden warns about the negative impact of price controls on drug pricing.
Share
More from Ron Wyden
Oct 10, 2026
As Congress debates solutions to protect our privacy and civil liberties, the MITRE report could provide important information about how these cameras and other surveillance programs are already impacting Americans’ rights.
Oct 8, 2026
This is another desperate attempt by a failed president to escape Americans’ revulsion with his failed agenda, amounting to one tank of Trump-inflated gas.
Oct 8, 2026
This throws doubt upon Treasury’s interpretation of many provisions of the Code, creates a great deal of uncertainty in the administration of our tax laws, and could balloon the deficit.
Oct 10, 2026
The White House should make MITRE’s findings public as soon as possible.





